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Abstract 
Steroid hormone concentrations are mostly determined by using different body fluids as matrices and 
applying immunoassay technologies. However, usability of these approaches may be restricted for 
several reasons, including ethical barriers for invasive sampling. Therefore, we developed an ultra-
performance LC-MS/MS method for high-throughput determination of concentrations of cortisol, 
cortisone, dehydroepiandrosterone (DHEA), and DHEA sulfate (DHEAS) in small quantities of 
human nails.   
The method was validated according to linearity, limits of detection and quantification, recovery, 
intra- and interassay precision, accuracy, and matrix effect. Samples from 10 adult women were 
analyzed to provide proof-of-principle for the method’s applicability. 
Calibration curves were linear (r2>0.999) in the ranges: 10-5000 pg/mg (for cortisol, cortisone, and 
DHEAS) and 50-5000 pg/mg (for DHEA). Limit of quantification amounted to 10 pg/mg for cortisol, 
cortisone, and DHEAS and 50 pg/mg for DHEA. The method showed good sensitivity and specificity 
without interferences for the analytes. The mean recoveries of cortisol, cortisone, DHEA and DHEAS 
were 90.5%, 94.1%, 84.9% and 95.9%, respectively, with good precision (coefficient of variation 
<14% for all analytes) and accuracy (relative error, %: -8.3% to 12.2% for all analytes). 
The median (pg/mg, range) hormone concentrations were 69.5 (36-158), 65 (32-133), 212 (50-1077), 
and 246 (115-547) for cortisol, cortisone, DHEA, and DHEAS, respectively.  
This method allows measuring cortisol, cortisone, DHEA, and DHEAS in small quantities of human 
nails, opening the way to develop applications in the field of endocrinology and beyond. 
Keywords: ultra performance liquid chromatography–tandem mass spectrometry (UPLC–MS/MS); 
hypothalamic-pituitary-adrenal (HPA) axis; keratin tissue; steroid 
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Introduction 
The hypothalamic-pituitary-adrenal (HPA) axis is a key regulator of numerous physiological 
processes [1]; dysfunction of this system’s hormones and related enzymes is associated with a variety 
of endocrinological diseases and syndromes, including Cushing’s syndrome [2], Addison’s disease [3] 
and metabolic syndrome [4], and has also been found to play a role in mental [5], immunological [6] 
and cardiovascular diseases [7], thereby placing a major challenge for public health [1]. Therefore, the 
assessment of HPA axis hormones is clinically and scientifically important in different disciplines, 
including endocrinology and psychiatry, and has come into focus in fields such as obstetrics and 
neonatology [8].  
Blood, urine, saliva, and hair are target tissues for the assessment of HPA axis hormones, and most 
approaches make use of immunoassay technologies, such as enzyme-linked immunosorbent assay or 
radioimmunoassay [9,10].	
  However, these methods face several limitations, including disadvantages 
of single point measurements (e.g. in blood, urine, saliva) reflecting only momentary hormone 
concentrations at the time of sampling, thereby covering only short periods of time, and being subject 
to intraindividual fluctuations, rapid degradation of analytes, risk of cross-reactivity, rather high 
quantification limits and, therefore, a relatively large amount of sample required; moreover, some of 
the methods are invasive (i.e. blood and cord blood sampling) and health personnel is required for the 
sample collection. 
Therefore, there is a strong need for non-invasive, easily applicable procedures overcoming previous 
limitations and for cumulative HPA biomarkers for research as well as diagnostic purposes. 
Addressing this need is in line with the strategic goal of major health initiatives, such as The 
Biomarkers Consortium managed by the Foundation for the National Institutes of Health. However, as 
yet, respective methods are scarce.  
There are several lines of evidence that support the use of nail as target tissue for measuring HPA axis 
hormones: First, cortisol and cortisone have previously been reported to be quantifiable in hair, 
another keratinized tissue [11]. Second, it has been shown previously that exogenous substances such 
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as arsenic [12], lead [13] and drugs [14] are incorporated into nail tissue, and that, third, also 
endogenous substances like testosterone and pregnenolone are quantifiable in human nail tissue [15]. 
Besides the immunoassay techniques mentioned above, hyphenated techniques were validated for the 
measurement of cortisol and cortisone in human and animal biological matrices with GC-MS and LC-
MS [16,17], as well as for the measurement of DHEA and DHEAS [18,19]. LC-MS/MS technology 
provides the opportunity to accurately determine hormone concentrations even in small amounts of 
sample. It has been shown previously that adrenal hormones can be assessed in biological fluids via 
LC-MS/MS [20-23].  
The main objective of this study was to develop an ultra-performance LC-MS/MS (UPLC-MS/MS) 
analytical method for the simultaneous measurement of cortisol, cortisone, dehydroepiandrosterone 
(DHEA) and dehydroepiandrosterone sulfate (DHEAS) in human nails, and provide proof-of-
principle for the method’s applicability. 
 
Experimental 
Chemicals 
Cortisol, cortisone and DHEA were obtained from Sigma (Saint-quentin Fallavier, France). DHEAS 
was purchased from Steraloids (Newport, USA). All analytical standards were purchased as crystal 
powder with a purity of > 98%. Deuterated cortisol (cortisol-d3) was obtained from Cambridge 
Isotope Laboratories (Andover, USA). 
HPLC-grade methanol (MeOH), isopropanol, formic acid (HCOOH) and ammonium hydroxide 
(NH4OH) were purchased from Prolabo (Fontenay-sous-bois, France). HPLC-grade acetonitrile 
(ACN) was obtained from Merck (Darmstadt, Germany), Oasis® HLB (30mg/30µm) solid-phase 
microextraction plate from Waters (Milford, USA). Water was purified by a Milli-Q system obtained 
from Millipore (Molsheim, France). 
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Solution preparation 
Cortisol, cortisone, DHEA and DHEAS solutions were prepared in MeOH at a final concentration of 
1, 0.1, 0.01, and 0.001 mg/L. Cortisol-d3 was prepared in MeOH at a final concentration of 1 mg/L. 
These solutions were refrigerated at 4°C until use and were stable at least for 6 months. 
Sorensen buffer was prepared by adding 38.8 mL KH2PO4 (9.07 g/L) to 6.12 mL Na2HPO4 (11.87 
g/L); pH value was adjusted to pH 7.6. 
 
Sample collection  
Calibration standards were prepared with nail samples from six members of our laboratory. To 
provide proof-of-principle of the method’s applicability, nails of the right thumbs from 10 adult 
women, recruited from the general community in the Basel region, were collected and analyzed. 
Participants gave written informed consent. Appropriate institutional ethics approval was obtained 
from the Ethics Committee of the States of Basel, Switzerland. 
  
Calibration standards and quality controls 
Nail clippings for calibration standards were washed ten times with warm deionized water and ten 
times with MeOH (~10 min for every cycle) in order to eliminate endogenous steroids for obtaining a 
pool of blank samples. Blank samples were analyzed to make sure that the four analytes were not 
detectable. Calibration was performed using 10 mg nails. Calibration standards were prepared at 
concentrations ranging from 10 to 5000 pg/mg of each analyte. 
To determine accuracy and intra- and interassay precision, quality controls were prepared by 
enriching 10 mg blank nails with the analytes tested at concentrations of 50, 200 and 1000 pg/mg. 
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Sample preparation 
Based on previous reports on successful decontamination of nails with double methanolic wash [24], 
nail clipping were washed once with warm deionized water and twice with methanol (1 mL) by 
vortexing 10 seconds. 
Samples were dried in an oven (45°C, 2 h) and cut into small pieces of 1-2 mm. Two to 15 mg of nails 
were incubated in 0.7 mL Sorensen buffer (pH 7.6) for 15 minutes in an ultrasonic bath, followed by 
incubation for 2 hours at 45°C, in the presence of 10 ng cortisol-d3 as internal standard. Based on 
previous reports on solid phase extraction for steroid analysis in keratin substance [11], for further 
purification, SPME Oasis® HLB extraction plates were used. Activation was operated with 0.2 mL 
MeOH, followed by 0.2 mL deionized water. The incubation medium was centrifuged and the 
supernatant was removed and deposited on the activated plate, then rinsed with 0.2 mL deionized 
water/MeOH (95:5, v/v). The plate was allowed to dry for 5 minutes at room temperature. Analytes 
were eluted with 35 µL ACN/isopropanol (40:60, v/v) with 2% of concentrated NH4OH, followed by 
35 µL deionized water. Ten µL of this extract were directly injected into the UPLC-MS/MS system. 
 
Instruments 
A Waters Acquity UPLC system (Milford, MA, USA) with a column heater, autosampler and a 10 µL 
injection loop was used. Analytes were separated at 30°C on a Waters Acquity UPLC BEH C18 
column (1.7 µL, 100 x 2.1-mm, i.d.). Separation was achieved using a gradient elution with 0.1% 
HCOOH (pH 2.6) and ACN at a flow rate of 0.4 mL/min (0 to 5 minutes: 90% HCOOH and 10% 
ACN; 5 to 6 minutes: 60% HCOOH and 40% ACN; 6 to 9.5 minutes: 90% HCOOH and 10% ACN). 
The total run time was 9.5 minutes, including periods required for injection and equilibrating the 
column before the next injection. 
Detection was performed using a Quattro Premier XE tandem Mass Spectrometry (MS/MS) (Waters-
Micromass, Manchester, UK) equipped with an electrospray ionization probe and operated switching 
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between positive and negative ionization mode. The capillary voltage was set to 3.5 kV in positive 
mode and 2.5 kV in negative mode. The ion source temperature was 120°C and the desolvation gas 
was heated to 350°C at a flow rate of 800 L/h. The cone gas was set at 50 L/h and collision gas 
(argon) pressure was maintained at 3.7 mbar. Multiple reactions monitoring (MRM) was employed to 
detect quantification and confirmation ions, as listed in Table 1. Data acquisitions were done using 
Masslynx® 4.1 software (Waters). 
[Insert Table 1 around here] 
 
Method validation 
The method was validated according to the following criteria: limit of detection (LOD), limit of 
quantification (LOQ), linearity, recovery, accuracy, intra- and interassay precision and matrix effect. 
Method validation was carried out with six analytical runs on five consecutive days. LOD and LOQ 
were determined by assaying a series of decreasing concentrations of the analytes in nails. LOD was 
defined as the lowest concentration where the signal of the compounds was equivalent to three times 
the background noise, and LOQ was defined as the lowest concentration with a signal-to-noise ratio 
of 10:1 and a coefficient of variation (CV) not greater than 20%. Linearity was tested by the 
preparation of calibration curves that ranged from LOQ to 5000 pg/mL for each analyte. A series of 
three curves was prepared with nine levels for cortisol, cortisone and DHEAS (10, 20, 50, 100, 200, 
500, 1000, 2000 and 5000 pg/mg), and seven levels for DHEA (50, 100, 200, 500, 1000, 2000 and 
5000 pg/mg). Linearity of the methods was investigated by calculation of the regression line by the 
method of least squares, and expressed by the correlation coefficient (r²). The extraction recovery was 
determined by comparing the peak areas of blank extracted samples spiked before extraction with the 
peak area of blank samples spiked after the extraction procedure. Three levels of cortisol, cortisone, 
DHEA and DHEAS concentrations (50, 200 and 1000 pg/mg) were tested. Intra- and interassay 
precision and accuracy were evaluated using three quality controls (50, 200 and 1000 pg/mg). 
Precision was expressed as CV, and accuracy was expressed as the relative error, defined as error 
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relative to the percentage of deviation between nominal and measured concentrations (relative error = 
(accuracy – 100) : 100). Matrix effect was evaluated using the method described by Matuszewski and 
colleagues [25]. Blank nails were extracted and fortified by analytes at three different concentrations 
(50, 200 and 1000 pg/mg; n=6) and analyzed (B). The peak areas were compared to directly injected 
standards at the same concentrations (A). Matrix effect was calculated using the formula: ME% = B/A 
x 100. Matrix effect values of 100% indicated no matrix effect, values < 100% indicated ion 
suppression, and values > 100% indicated ion enhancement. 
 
Statistics 
In addition to absolute hormone concentrations, we determined the cortisol/cortisone ratio, 
cortisol/DHEA ratio, cortisol/DHEAS ratio, and DHEA/DHEAS ratio, which have been associated 
with a variety of diseases, for example related to the reproductive, immune, metabolic and central 
nervous system [26-28], as indicators of enzymatic activity. Besides allowing the study of hormone 
metabolism and enzyme activity, hormone ratios facilitate the comparison of results between studies 
that used different analytical methods.  
As indicators of mutual interdependence of the concentrations of the four analytes, we estimated the 
association between the concentrations of cortisol, cortisone, DHEA and DHEAS using Kendall's τ. 
All tests were two-tailed and we set the level of significance at 0.05. For statistical analyses, we used 
SPSS software (version 17.0).  
 
Results  
UPLC-MS/MS characteristics 
In UPLC conditions, cortisol, cortisone, DHEA and DHEAS were sufficiently separated 
chromatographically (Figure 1). The mean (± standard deviation) retention times were 4.51 ± 0.09 
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minutes for cortisol, 4.59 ± 0.09 minutes for cortisone, 6.49 ± 0.09 minutes for DHEA and 5.35 ± 
0.09 minutes for DHEAS. Analysis of six samples of blank nails, Sorensen buffer and deionized water 
showed no interfering peaks at the retention time of any of the steroids, nor the internal standards 
examined. 
[Insert Figure 1 around here] 
 
Method validation 
Linearity, LOD, LOQ, recovery and sensitivity 
LOQs in nails were 10 pg/mg (CV < 8.7%) for cortisol, cortisone, and DHEAS and 50 pg/mg for 
DHEA (CV < 10.3%), respectively (Figure 2).  
[Insert Figure 2 around here] 
LODs ranged from 5 pg/mg for cortisol, cortisone, and DHEAS to 20 pg/mg for DHEA. The 
calibration curves showed good linear responses (r² > 0.999) over the range from 10 to 5000 pg/mg 
for cortisol, cortisone and DHEAS and 50 to 5000 pg/mg for DHEA, using ⅟x² weighing factor. Table 
2 shows the recovery and matrix effect tested for each analyte at three different concentrations (50, 
200 and 1000 pg/mg; n=6). The extraction recoveries were > 87% for cortisol, > 91% for cortisone, > 
82% for DHEA and > 93% for DHEAS. No significant matrix effect was observed in the nails tested 
(relative error between 90 and 105% for the different analytes). 
[Insert Table 2 around here] 
 
Precision and accuracy  
Accuracy and intra- and interassay precision of the method were determined by analyzing replicate 
nail samples (n = 6), containing analytes of interest at concentrations of 50, 200 and 1000 pg/mg, at 
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the same day and on five consecutive days. The interassay values were based on five batches of n = 6 
nails each. The results of these analyses are summarized in Table 3. Intra- and interassay precision 
calculated from repeated analyses was < 14% for all analytes. Accuracy expressed in terms of relative 
error ranged from -8.3% to 12.2% for the four compounds at all concentrations. 
[Insert Table 3 around here] 
 
Applications 
UPLC-MS/MS was performed on fingernail samples of 10 adult women (age: median [range]: 32.5 
[29-39] years). For the analyses, at least 1 mg of nail tissue was required. All participants provided 
more than 1 mg of nail sample (median [range]: 5.7 [2.4-10.6] mg).  
All cortisol, cortisone, DHEA and DHEAS concentrations were above the LOQ (Table 4). Cortisol 
concentrations ranged from 36 to 158 pg/mg with a median value of 69.5 pg/mg; cortisone 
concentrations ranged from 32 to 133 pg/mg with a median value of 65 pg/mg; DHEA concentrations 
ranged from 50 to 1077 pg/mg with a median value of 211.5 pg/mg; and DHEAS concentrations 
ranged from 115 to 547 pg/mg with a median value of 245.5 pg/mg.  
[Insert Table 4 around here] 
Cortisol/cortisone ratios ranged from 0.98 to 1.26 with a median value of 1.13; cortisol/DHEA ratios 
ranged from 0.10 to 2.14 with a median value of 0.21; cortisol/DHEAS ratios ranged from 0.25 to 
0.34 with a median value of 0.28; and DHEA/DHEAS ratios ranged from 0.14 to 2.55 with a median 
value of 1.31.  
The concentrations of cortisol and cortisone, cortisol and DHEAS, and cortisone and DHEAS, 
respectively, were positively associated (all P < 0.05). The Kendall’s τ correlation coefficients are 
depicted in Table 5. 
[Insert Table 5 around here] 
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Discussion 
We developed an analytical method to simultaneously measure cortisol, cortisone, DHEA and 
DHEAS in small quantities of human nails, using an LC-MS/MS assay, with good linearity, 
sensitivity, specificity and accuracy without interferences between the four molecules and a low limit 
of quantification. All hormones were quantifiable in nails of healthy adult women.  
The cortisol LOQ of the here reported method was comparable to those of an enzyme immunoassay 
(EIA) method established for cortisol and DHEA determination in saliva that was previously used for 
the measurement of cortisol and DHEA in nails [29]. However, the here reported DHEA 
concentrations were 5 to 10 times higher than those previously measured with the EIA method for 
which data about accuracy were not reported [29]. In addition, we were able to quantify the four 
substances in quantities of nail substance as low as 1 mg. This is 50 times lower than the amount of 
nail substance used in previously reported analyses of cortisol and DHEA using EIA [29]. Therefore, 
UPLC-MS/MS allows easy and accurate concomitant assessment of cortisol, cortisone, DHEA and 
DHEAS in minimal amount of nail sample with high specificity and sensitivity and without 
interferences due to cross-reactivity with endogenous and exogenous steroids, as compared to 
immunoassays [22]. 
The cortisol concentrations detected in nails were higher than the previously reported cortisol 
concentrations in human hair measured with liquid chromatography mass spectrometry [11], while 
cortisone concentrations were virtually identical, ranging between 12 and 163 pg/mg in the previous 
study [11] and between 32 and 133 pg/mg in our data, which resulted in higher cortisol/cortisone 
ratios in nail as compared to hair. One possible explanation for this difference could be the wash-out 
of cortisol from hair [10], which may occur less in nails. Another explanation could be the differences 
in tissue incorporation. Alternatively, there may be higher hydroxysteroid (11-beta) dehydrogenase 2 
(HSD11B2) activity in hair-associated tissues (e.g. sweat glands [11]), leading to lower 
cortisol/cortisone ratios in hair as compared to nail.  
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The cortisol/cortisone ratios detected in nails were approximately 2.5 to 10 times higher than those 
previously reported for saliva [20,21] and approximately 2 to 10 times lower than those previous 
reported in total and free plasma/serum [30,23] measured by different types of MS/MS. The 
cortisol/cortisone ratios detected in nails were in the same range as previously reported free urinary 
cortisol/cortisone ratios measured with different types of MS [22,31,17], and, interestingly, virtually 
identical to the ratio of their tetrahydro- and allo-tetrahydro-metabolites (THF + allo-THF)/(THE + 
allo-THE) (ranging between 1.01 to 1.23) recently determined by HPLC combined with fluorescence 
derivatization [32], indicating that the cortisol/cortisone ratio measured in nail may reflect the same 
physiological processes as the urinary ratio, above all the net balance of corticosteroid 11-beta-
dehydrogenase isozyme 1 (HSD11B1) and corticosteroid 11-beta-dehydrogenase isozyme 2 
(HSD11B2) activity [33] (see Figure 3). Indeed, it has been reported in human subjects that cortisol 
concentrations in keratinized tissue are not associated with those in saliva but with cortisol 
concentrations in urine [34]. 
[Insert Figure 3 around here] 
 
Cortisol/DHEA ratios were lower than those previously determined in serum, saliva and nails 
assessed by immunoassays [29,28,35], while the here reported cortisol/DHEAS ratios were higher 
than those previously determined in serum and saliva by immunoassays [27,36,35]. Potential 
explanations may be differences in assay characteristics between UPLC-MS/MS and immunoassay 
methods, differences in age and gender of the participants, and differences in processes of 
incorporation of the substances from blood into saliva or nails, respectively, as described below. 
DHEA/DHEAS ratios were substantially higher than those previously determined in serum by 
radioimmunoassay [37]. This could be explained by tissue-specific activity of steryl-sulfatase (STS) 
and bile salt sulfotransferase (SULT2A1), enzymes involved in the interconversion between DHEA 
and DHEAS [38,26] (see Figure 3). Indeed, sulfatase activity has previously been detected in nail 
tissue [39], where sulfatase deficiency is the basis defect of recessive X-linked ichthyosis [40].  
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Moreover, nail permeability to substances was shown to be negatively correlated to the molecular 
weight and the ionization of the molecule; it is significantly lower for ionic substances than for non-
ionic substances and for substances with higher molecular weight, this in spite of the lipophilicity of 
the substances (40). As DHEA has a lower molecular weight (288.42 g/mol) than DHEAS (368.49 
g/mol) cortisol (362.46 g/mol), and cortisone (360.44 g/mol), nails permeability coefficient for DHEA 
could be significantly higher than for DHEAS, cortisol, and cortisone which could in part explain the 
reversed hormone ratios compared to those found in the human biological fluids.  
The nail concentrations of cortisol and cortisone, cortisol and DHEAS, and cortisone and DHEAS 
were mutually associated, suggesting that they partially reflect a shared underlying process, which 
may not be reflected by DHEA concentrations. 
Evidence on potential routes of substance incorporation into the nail comes from a variety of in vitro 
and in vivo studies on nail permeability to drugs, suggesting that incorporation of drugs into the nail 
most likely occurs simultaneously via two ways, the nail matrix (located at the proximal ventral 
surface of the nail, responsible for cell proliferation and nail growth) and the nail bed filled with blood 
vessels [for details, see 14,41]. Nails grow along two different directions, length and thickness, with 
rates of 0.1 mm/day and 0.027 mm/day length growth, respectively [14]. Altogether, these data 
suggest that human nail matrix is likely to reflect cumulative endogenous hormone concentrations 
covering several weeks up to months rather than providing a snapshot of a short period of time [14]. 
This indicates the potential of the nail as matrix carrying biomarkers for chronic physiological 
processes. One advantage for the use of nail over hair, another keratin tissue, is the fact that the nail 
lacks pigments, such as different types of melanin, which may influence the affinity of the hair matrix 
for different substances [42].  
Our study has several strengths. We developed a method with numerous advantageous characteristics, 
including non-invasive sample collection and convenient sample storage at room temperature, 
allowing ambulatory sample collection by study participants, low minimal amount of required sample, 
and a total analytical run time of 9 minutes for simultaneously assessing several hormones. Using 
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state-of-the-art approaches, we confirmed their high sensitivity and specificity, good accuracy and 
reproducibility. Furthermore, the UPLC-MS/MS method is free of interference in contrast to EIA. 
Finally, we provided proof-of-principle for using the method to determine hormone concentrations in 
human nails, opening the way for its further development for a wide range of potential applications in 
research and clinical settings, for example as a screening tool.  
One limitation of our method is that we cannot finally exclude that decontamination of the samples 
extracted parts of the endogenous hormones, thereby reducing the detectable hormone levels. We 
dealt with this limitation by additionally calculating hormone/metabolite ratios, which are more robust 
against underestimation, as aberrant decontamination would relate to both hormone and metabolite. 
Finally, it may be speculated that cosmetic products influence incorporation of endogenous hormones 
into the nail. However, 4 out of the 10 women reported use of nail polish and nail polish remover, but 
concentrations of all four hormones were virtually identical in those using and not using nail polish 
(data not shown). 
Future studies should further address the role of cosmetics and hygiene. Moreover, future studies 
should aim at further reducing the minimum amount of required sample by increasing the sensitivity 
of the method, for example using gas-chromatography instead of LC. Analytical methods to measure 
DHEA in hair with a LOQ at 0.5 pg/mg have recently been described [43]. Finally, further studies 
should test the functional significance of the method and provide data on its validity. Indeed, as proof 
of principle, we have recently shown that DHEA concentrations in nails of infants are associated with 
intrauterine exposure to maternal stress [44].  
The method may have the potential for future applications in different fields of endocrinology and 
beyond, offering a non-invasive tool to assess cumulative steroid concentrations in pathological 
conditions characterized by disturbances of steroid hormones and related enzymatic activity. 
To the best of our knowledge, this is the first study demonstrating that cortisol and DHEA, and their 
metabolites cortisone and DHEAS, are simultaneously detectable and quantifiable in small amounts of 
human fingernail, using a simple and reproducible LC-MS/MS assay with good linearity, sensitivity, 
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specificity and accuracy without interferences for the four molecules and a low LOQ. It may be a 
useful easily accessible biomarker providing cumulative information on HPA hormone concentrations 
and related enzymatic activity. This non-invasive method may be a promising tool for a wide range of 
clinical and research applications in the field of endocrinology and beyond. 
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Table 1: Multiple reactions monitoring parameters for cortisol, cortisone, DHEA, DHEAS, and 
internal standard detection 
Compound Precursor/parent 
ion (m/z) 
Product/daughter 
ion (m/z) 
Cone voltage (V) Collision energy 
(eV) 
Cortisol 363.1 
363.1 
120.9* 
309.0 
35 
35 
20 
10 
Cortisone 361.1 
361.1 
163.0* 
120.9 
40 
40 
25 
20 
DHEA 289.1 
289.1 
253.1* 
213.1 
20 
20 
10 
15 
DHEAS 367.1 96.8* 50 30 
Cortisol-d3 366.1 120.9 35 20 
* quantification ion  
DHEA = dehydroepiandrosterone, DHEAS = dehydroepiandrosterone sulfate. 
	
  
Table 2: Extraction recovery and matrix effect 
  Recovery (n = 6) Matrix Effect (n = 6) 
Compound (pg/mg) % CV (%) % CV (%) 
Cortisol 50 
200 
1000 
87.8 
89.5 
94.1 
7.6 
6.5 
5.0 
90.0 
91.5 
95.3 
11.6 
9.5 
9.1 
Cortisone 50 
200 
1000 
91.4 
93.7 
97.2 
8.3 
5.1 
4.7 
98.9 
96.6 
99.1 
10.8 
10.2 
8.9 
DHEA 50 
200 
1000 
82.9 
84.6 
87.3 
10.9 
9.8 
9.1 
93.9 
94.7 
96.1 
12.9 
12.2 
10.4 
DHEAS 50 
200 
1000 
93.4 
95.8 
98.6 
6.4 
6.1 
4.3 
105.4 
103.7 
98.5 
11.4 
9.8 
9.2 
CV = coefficient of variation, DHEA = dehydroepiandrosterone, DHEAS = dehydroepiandrosterone 
sulfate. 
	
  
Table 3: Precision and accuracy 
  Intra-assay (n = 6) Inter-assay (n = 6) 
Compound (pg/mg) Precision 
(CV, %) 
Accuracy 
(RE, %) 
Precision 
(CV, %) 
Accuracy 
(RE, %) 
Cortisol 50 
200 
1000 
9.2 
7.8 
6.3 
4.9 
3.8 
-0.6 
11.7 
10.9 
8.9 
12.2 
9.4 
5.9 
Cortisone 50 
200 
1000 
8.6 
8.2 
5.9 
-0.1 
-2.2 
-4.9 
12.4 
10.1 
9.7 
6.4 
4.9 
0.7 
DHEA 50 
200 
1000 
10.4 
9.9 
8.1 
-1.4 
-2.7 
2.6 
13.5 
12.1 
11.7 
-8.3 
-6.4 
-5.9 
DHEAS 50 
200 
1000 
8.8 
7.5 
5.4 
-2.7 
2.8 
3.7 
11.2 
10.6 
9.9 
1.5 
3.1 
5.9 
CV = coefficient of variation, RE = relative error, DHEA = dehydroepiandrosterone, DHEAS = 
dehydroepiandrosterone sulfate. 
	
  
Table 4: Concentrations of cortisol, cortisone, DHEA and DHEAS in nail samples of 
participants. 
Subject 
No 
Cortisol 
(pg/mg) 
Cortisone 
(pg/mg) 
DHEA 
(pg/mg) 
DHEAS 
(pg/mg) 
1 70 66 447 252 
2 36 32 196 130 
3 69 64 199 239 
4 107 85 50 354 
5 158 133 97 547 
6 53 54 224 202 
7 115 102 128 345 
8 105 92 1077 422 
9 65 63 393 232 
10 39 32 287 115 
DHEA = dehydroepiandrosterone, DHEAS = dehydroepiandrosterone sulfate. 
Table 5: Kendall’s τ  coefficients (P-values) of the associations between cortisol, cortisone, 
DHEA, and DHEAS concentrations in nail samples of participants. 
 Cortisol  Cortisone  DHEA  DHEAS  
Cortisol  – – 
0.944*  
(< 0.001) 
–0.156 
(0.531) 
0.822* 
(0.001) 
Cortisone  – –  – – 
–0.135 
(0.590) 
0.899* 
(< 0.001) 
DHEA  – – – – – – 
–0.156 
(0.531) 
* P < 0.05 
DHEA = dehydroepiandrosterone, DHEAS = dehydroepiandrosterone sulfate. 
	
  
Figure legends 
Figure 1: Chromatogram of a nail extract. Concentrations measured were 66 pg/mg, 70 pg/mg, 447 
pg/mg, and 252 pg/mg, respectively, for cortisone, cortisol, dehydroepiandrosterone, and 
dehydroepiandrosterone sulfate. The y-axis represents relative signal intensity. 
Figure 2: Chromatogram of blank nails spiked with cortisone, cortisol, dehydroepiandrosterone, and 
dehydroepiandrosterone sulfate at limits of quantification (10, 10, 50 and 10 pg/mg respectively). 
Retention times were 4.59, 4.51, 6.49, and 5.35 minutes, respectively. The y-axis represents relative 
signal intensity. 
Figure 3: Chemical structure and metabolic dependency of cortisol, cortisone, 
dehydroepiandrosterone (DHEA), and dehydroepiandrosterone sulfate (DHEAS).	
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